Pain - Journavx Drug Quantity Management Policy - Per Days
Defines drug quantity limits and exception criteria for Journavx (suzetrigine tablets) for Cigna-administered health benefit plans, affecting prescribers, pharmacists, and utilization reviewers.
New policy created for Journavx drug quantity management.
Coverage Criteria
Quantity Limit Exceptions (one-time overrides)
Exceptions to the 30-tablet per 90-day limit are covered as medically necessary only when the following conditions are met:
approval duration = 30 days
Receipt of sample product does not satisfy criteria
Any exception request that is not one of the exceptions specifically listed in this policy is considered not medically necessary.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.